Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype

ABSTRACT: Details continue to emerge on psoriatic arthritis, expanding our understanding of its pathogenesis and clinical features. This has led to the evolution of management guidelines, which now recognize additional disease manifestations. In this rapidly changing area, it is timely to review the...

Descripción completa

Detalles Bibliográficos
Autor principal: Marchesoni, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251836/
https://www.ncbi.nlm.nih.gov/pubmed/29858769
http://dx.doi.org/10.1007/s40744-018-0115-5
_version_ 1783373154551332864
author Marchesoni, Antonio
author_facet Marchesoni, Antonio
author_sort Marchesoni, Antonio
collection PubMed
description ABSTRACT: Details continue to emerge on psoriatic arthritis, expanding our understanding of its pathogenesis and clinical features. This has led to the evolution of management guidelines, which now recognize additional disease manifestations. In this rapidly changing area, it is timely to review the latest evidence and discuss whether management strategies are meeting patients’ needs. FUNDING: Celgene Corporation.
format Online
Article
Text
id pubmed-6251836
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-62518362018-12-10 Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype Marchesoni, Antonio Rheumatol Ther Commentary ABSTRACT: Details continue to emerge on psoriatic arthritis, expanding our understanding of its pathogenesis and clinical features. This has led to the evolution of management guidelines, which now recognize additional disease manifestations. In this rapidly changing area, it is timely to review the latest evidence and discuss whether management strategies are meeting patients’ needs. FUNDING: Celgene Corporation. Springer Healthcare 2018-06-01 /pmc/articles/PMC6251836/ /pubmed/29858769 http://dx.doi.org/10.1007/s40744-018-0115-5 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Commentary
Marchesoni, Antonio
Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype
title Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype
title_full Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype
title_fullStr Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype
title_full_unstemmed Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype
title_short Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype
title_sort oligoarticular psoriatic arthritis: addressing clinical challenges in an intriguing phenotype
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251836/
https://www.ncbi.nlm.nih.gov/pubmed/29858769
http://dx.doi.org/10.1007/s40744-018-0115-5
work_keys_str_mv AT marchesoniantonio oligoarticularpsoriaticarthritisaddressingclinicalchallengesinanintriguingphenotype

Ejemplares similares